Fill in your personal details and a hospital representative will contact you within 48 hours to offer you options regarding your request. Patients requesting appointments must have a referral from their personal doctor.
Fill in your personal details and a hospital representative will contact you within 48 hours to offer you options regarding your request. Patients requesting appointments must have a referral from their personal doctor.
Cell Therapy, Telemedicine
EDUCATION
1. September 2020: Postgraduate Student at the School of Economics and Business Administration (MBA)
2. June 2018: Postgraduate degree from the Open University of Cyprus in the field of “”Applied Informatics in Health and Telemedicine””
3. June 2010: Postgraduate degree program in “”thérapie cellulaire”” at Université Paris Diderot Paris 7
4. July 2009: obtaining a specialty title, General Hospital Papanikolaou, Hematology Clinic and Bone Marrow Transplant Center, Thessaloniki
5. July 1999: Degree in Medicine, Aristotle University of Thessaloniki
6. June 1992: High school leaving certificate
LANGUAGES
• GREEK (Mother tongue)
• FRENCH (DALF 2004)
• ENGLISH (TOEFL 2010)
PUBLICATIONS(15)
CITATIONS 150
CONFERENCES (56)
WORKING GROUPS – SEMINARS (32)
SPEECHES – ANNOUNCEMENTS (12)
PAPERS – ANNOUNCEMENTS (47)
AWARDS
1st prize for oral presentation in its category. Athens 2008
“”Multicentric perspective recording of resistant germs in febrile neutropenic patients with hematological malignancies””, A. Pouli, D. Sotiropoulos, A. Manaka, N. Neokleous, M. Costopoulou, M. Pagoni, A. Rekleiti, A. Sioni, P. Lambropoulou, V. Gastari, L. Chatzichannas, C. Mitsouli, S. Gigantes, A. Anagnostopoulou, G. D. Daikos, G. Petrikkos, Athens 2008.
BIBLIOGRAPHY
Ν. Neokleous, G. Karianakis (2011) “”Immunology in transplantation””. Tsakraklidis Vassilis “”Lymphatic Tissue Pathology”” (pp. 185-194). Athens Zevelekakis Publications.
PARTICIPATION IN STUDIES AND PROTOCOLS (3)
1. Investigator in the clinical trial of Velcade 26866138MMY4008 entitled “”observational study of Velcade ”.
2. Investigator in a clinical study entitled “”Imatinib vs Dasatinib as first line therapy””. Bristol Myers-Squibb.
3. Participation in multicentre retrospective study for recording infections in neutropenic patients.
1. 2/5/2011 to date: Medical Officer – Hematology Limassol GH. 2. 1/9/2010- 14/4/2011: Associate Hematologist in Hematology of Ygeia Hospital, Athens 3. 30/6/2009- 30/6/2010: Hematologist at Stem Cell Bank, Stem-Health Hellas SA Ygeia Hospital. 4. 10/03/2005 -11/04/2009: Resident in Hematology, Hematology Clinic and “Storgi” Centre, Papanicolaou GH, Thessaloniki • 15/09/2007 -15/12/2007: Training in the “Thrombosis and Hemophilia” Department of the Royal Free Hospital in London. • 22/09/2006-22/11/2006: Training in “hemoglobinopathies” at Hippocratic Hospital Thessaloniki 5. 21/08/2002- 14/01/2005: Resident of Internal Medicine at the 2nd Pathology Clinic of Papageorgiou Hospital. 6. 22/01/2001- 22/05/2002: Military service as in the Neurological Clinic 492 Alexandroupolis Miltary Hospital 7. 23/08/1999 -26/11/2000: Rural Service in Rural Terpyllos Health Centre Polykastro Kilkis (including the 3-month compulsory training at Kilkis GH)
